(NVO) Novo Nordisk - Performance -42.9% in 12m
NVO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
47.19%
#17 in Peer-Group
Rel. Strength
12.86%
#6633 in Stock-Universe
Total Return 12m
-42.86%
#150 in Peer-Group
Total Return 5y
165.07%
#10 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 20.3 |
| P/E Forward | 18.1 |
| High / Low | USD |
|---|---|
| 52 Week High | 144.04 USD |
| 52 Week Low | 58.08 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 92.86 |
| Buy/Sell Signal +-5 | -1.61 |
| Support / Resistance | Levels |
|---|---|
| Support | 65.7 |
| Resistance | 108.8, 103.6, 85.6, 81.3 |
12m Total Return: NVO (-42.9%) vs XLV (-5.2%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-0.75% | 122% | 360% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
10.1% | -6.61% | 514% | 62.1 | 35.1 | 1.17 | 58.2% | 18.9% |
| NVS NYSE Novartis |
11.8% | 16.7% | 81.6% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
7.84% | 6.76% | 54.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| SFZN SW Siegfried Holding |
-0.84% | 2.5% | 140% | 26.2 | 25.6 | 1.48 | 77.8% | 77.6% |
| GSK NYSE GlaxoSmithKline |
13.7% | 3.77% | 57.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
9.89% | -4.53% | 58.6% | 28.9 | 15.9 | 0.96 | 52.7% | 22.3% |
| IPN PA Ipsen |
2.14% | -15% | 54.2% | 24.4 | 10.3 | 0.74 | -6.40% | -6.33% |
Performance Comparison: NVO vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for NVO
| Total Return (including Dividends) | NVO | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 22.06% | 3.23% | 1.73% |
| 3 Months | 6.89% | -4.99% | 8.59% |
| 12 Months | -42.86% | -5.21% | 11.46% |
| 5 Years | 165.07% | 50.53% | 109.12% |
| Trend Score (consistency of price movement) | NVO | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 97% | 65.8% | 69.9% |
| 3 Months | 19.3% | -72% | 69.3% |
| 12 Months | -95.5% | -62.2% | 43.2% |
| 5 Years | 89.6% | 88.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #34 | 18.24% | 19.99% |
| 3 Month | #71 | 12.50% | -1.57% |
| 12 Month | #149 | -39.72% | -48.73% |
| 5 Years | #10 | 76.09% | 26.76% |
FAQs
Does Novo Nordisk (NVO) outperform the market?
No,
over the last 12 months NVO made -42.86%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.21%.
Over the last 3 months NVO made 6.89%, while XLV made -4.99%.
Performance Comparison NVO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
NVO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 7.3% | 20.3% | -23.6% | -54% |
| US NASDAQ 100 | QQQ | 7.5% | 19.9% | -23.8% | -54% |
| German DAX 40 | DAX | 10.2% | 22.7% | -38.9% | -71% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 7.3% | 23% | -24% | -55% |
| Hongkong Hang Seng | HSI | 6% | 16.3% | -40.5% | -70% |
| India NIFTY 50 | INDA | 8.6% | 22% | -22.1% | -43% |
| Brasil Bovespa | EWZ | 5.5% | 22.7% | -40.8% | -51% |
NVO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 8.1% | 19.7% | -26.3% | -67% |
| Consumer Discretionary | XLY | 7.2% | 23.7% | -14.5% | -62% |
| Consumer Staples | XLP | 7.9% | 20.8% | -24.1% | -51% |
| Energy | XLE | 1.4% | 19.3% | -24.5% | -45% |
| Financial | XLF | 9.5% | 24.3% | -25.8% | -67% |
| Health Care | XLV | 5.7% | 18.8% | -21.5% | -38% |
| Industrial | XLI | 8.5% | 21.1% | -28.8% | -61% |
| Materials | XLB | 7.4% | 20.6% | -23.1% | -42% |
| Real Estate | XLRE | 7% | 20.1% | -23.6% | -55% |
| Technology | XLK | 6.6% | 19.2% | -24.5% | -49% |
| Utilities | XLU | 6.7% | 19.8% | -30.6% | -63% |
| Aerospace & Defense | XAR | 7.2% | 13.9% | -42.2% | -84% |
| Biotech | XBI | 7.8% | 14.3% | -13.7% | -32% |
| Homebuilder | XHB | 7.9% | 29% | -6.9% | -33% |
| Retail | XRT | 10.8% | 20.9% | -15.5% | -44% |
NVO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -5.4% | 6.78% | -32.3% | -49% |
| Natural Gas | UNG | 11.7% | 32.1% | -39.1% | -24% |
| Gold | GLD | 3.3% | 16.4% | -53.6% | -91% |
| Silver | SLV | 6.1% | 11.9% | -43% | -68% |
| Copper | CPER | 8.5% | 20.8% | -38.1% | -51% |
NVO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 5.8% | 21.2% | -22% | -39% |
| iShares High Yield Corp. Bond | HYG | 6.9% | 21.7% | -27% | -52% |